Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies
about
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseA meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosisGlitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort StudyTracking Parkinson's: Study Design and Baseline Patient Data.Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.Single injection of small-molecule amyloid accelerator results in cell death of nigral dopamine neurons in miceNetwork analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.Thiazolidinediones and Parkinson Disease: A Cohort Study.Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro.Increased risk of Parkinson disease with diabetes mellitus in a population-based study.Association between Parkinson's disease and diabetes: Data from NEDICES study.Glycation in Parkinson's disease and Alzheimer's disease.Neuroendocrine abnormalities in Parkinson's disease.Cardiovascular Diseases in ~30,000 Patients in the Swedish Dementia Registry.Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson's disease.Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice.Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes.Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.Glitazone use associated with reduced risk of Parkinson's disease.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Comorbid Conditions in Parkinson's Disease: A Population-Based Study of Statewide Parkinson's Disease Registry.Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.The Therapeutic Potential of Metformin in Neurodegenerative Diseases
P2860
Q28074143-003D024E-A183-4375-A7F3-3ED3710482A5Q28383030-BA06D1C1-9B88-4AD8-879F-2AFFA965794FQ28546721-684F9FE3-101C-4674-8BDE-AE3CD6C0ED24Q31008758-432707AA-8557-4596-A8C1-03DCA7597198Q33731321-38A80CE8-FFEB-4317-82D6-A75F5B194844Q33917228-41D5FC71-5190-4648-A0D9-3F1B1D100FD5Q34287243-DFC10082-C991-495A-98BF-E081CC50D385Q35129144-BDE3DA53-4A92-435C-919D-AB6513282608Q36209650-833D3EDF-754F-46EB-8003-327D7B6AB75CQ36306620-ACA9C6A3-B475-406E-ACA5-423DBD5FD8B3Q36891855-CD39B661-757D-4231-8E3A-468D129C7039Q37267127-2EBD32EA-D282-4400-A559-015B4DD71EB5Q37613409-775621DF-F762-41E6-A1CD-0ECCED00FCD9Q38707675-6A6B0246-5DFD-4535-8A9F-97F1931AFEF1Q38762228-EF93D00F-EDD5-4C3D-BFC9-46542D00CCEAQ38801525-1268B819-D564-47E9-B3DF-C19F179AD9A8Q41324336-1EF297B1-91E1-4C64-8343-4955908F339DQ41858992-5D2640B3-6653-4863-805C-48C27586F3E5Q42416060-5C26EA75-61A1-4293-B0B5-5468470E43D1Q45232246-708E7D1C-E764-4CE7-88E8-7C12C0B257F9Q46184142-01358444-8773-4173-9926-BA6B094C2A01Q47101135-04DFD865-D90E-49CC-92D1-0B9C6DEC5609Q47137783-585FAE36-C391-4F05-8300-A6F736580557Q47252854-BF65263A-F7F7-4FDB-B6BA-E247C451E91BQ48565252-B00280F5-9447-4ED9-82FB-4D454251F9DDQ52373049-1F821A77-CC6A-43F4-A30E-9C5F60ABA6D0Q55226753-AEAB39FD-1ABE-41D7-946D-9F3472610E65Q57175337-07495DD0-34B2-4F24-A37C-2BF04EA7B23A
P2860
Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diabetes and risk of Parkinson ...... alysis of case-control studies
@ast
Diabetes and risk of Parkinson ...... alysis of case-control studies
@en
Diabetes and risk of Parkinson ...... alysis of case-control studies
@nl
type
label
Diabetes and risk of Parkinson ...... alysis of case-control studies
@ast
Diabetes and risk of Parkinson ...... alysis of case-control studies
@en
Diabetes and risk of Parkinson ...... alysis of case-control studies
@nl
prefLabel
Diabetes and risk of Parkinson ...... alysis of case-control studies
@ast
Diabetes and risk of Parkinson ...... alysis of case-control studies
@en
Diabetes and risk of Parkinson ...... alysis of case-control studies
@nl
P2093
P2860
P3181
P1433
P1476
Diabetes and risk of Parkinson ...... alysis of case-control studies
@en
P2093
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0085781
P407
P577
2014-01-01T00:00:00Z